Journal of Antivirals & Antiretrovirals
Open Access

Virology Department, National Institute of Cholera and Enteric Diseases, Indian Council of Medical Research, Kolkata, India

Publications

• Mini Review   
  Covid-19 Pandemic and Vaccine Prospect: Lessons Learnt from HIV/AIDS
  Author(s): Gautam Kr Ghosh*
  
  Recent media reported in India those weeks after first vaccine dose during the trial, a Minister got Covid-19. It may have hogged the headline in regard to India’s Covaxin produced by Bharat Biotech. But, the company soon issued a statement defending itself on this count stating, “Covaxin clinical trials are based on a two-dose schedule, given 28 days apart, and the vaccine has been designed to be efficacious when subjects receive both doses.”.. View More»
  DOI: 10.35248/1948-5964.21.13.209

  Abstract HTML PDF